Advertisement

Avanos Medical, Inc. AVNS

Set alert

Price alert · AVNS

All alert types
24.99 USD 0.00 0.00%

At close · Jul 24

24.95 -0.04 -0.16%

After hours · Jul 24, 4:03 PM ET

Bid
24.93 × 46,800
Ask
24.94 × 3,700
24.98 Day range 25.00
10.64 52-week range 25.49
YTD
+122.53%
1 year
+105.34%
Open
24.98
Prev close
24.99
Mkt cap
1.17B
Vol
432.16K
Avg vol
700.36K
EPS
-1.61
P/E
23.58
Div yield
0.00%
More statistics
Low
24.98
High
25.00
Beta
1.57
Inst. own
93.15%
Dividend
0.00
Earnings
Aug 10, 2026

3M chart

Chart tools
Interval

Events in this range
  • May 5, 2026Earnings: 0.22; estimate 0.16; surprise 37.5%
Signals (7)
NameDateAgo
SMA: BullishJul 15, 20263 months ago
SMA: BullishJul 2, 20264 months ago
SMA: BullishJul 2, 20264 months ago
SMA: BearishJul 1, 20264 months ago
SMA: BearishJun 30, 20264 months ago
RSI: OverboughtJun 18, 20264 months ago
MACD: Sell SignalMay 1, 20266 months ago

Key statistics

Market cap
1.17B
Enterprise value
1.24B
Trailing P/E
-16.65
PEG ratio
-0.39
Price / sales
1.64
Price / book
1.48
Beta
1.57
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-9.69%
Total cash
0
Total debt
3
Return on equity
-8.91%

Analyst view

Price target (mean) —
Ratings (0m) 1 0 buy · 1 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Aug 10, 2026

Expected Aug 10, 2026. Consensus EPS estimate 0.16.

Earnings history

Financials — quick view

All financials
AVNS Revenue — quarterly 182.20M
2022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 2026
AVNS Net income — quarterly 5.10M
2022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 2026
AVNS EPS — quarterly 0.11
2022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 2026

Earnings

AVNS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Aug 10, 2026Jun 30, 20260.16———
May 5, 2026Mar 31, 20260.160.22+0.06+37.50%
Feb 24, 2026Dec 31, 20250.240.29+0.05+20.83%
Nov 5, 2025Sep 30, 20250.120.22+0.10+83.33%
Aug 5, 2025Jun 30, 20250.180.17-0.01-5.56%
May 6, 2025Mar 31, 20250.190.26+0.07+36.84%

Upgrades / downgrades

AVNS analyst upgrades and downgrades
DateFirmActionFromTo
May 7, 2024JMP Securitiesreit—Market Perform
Jul 25, 2023KeybancdownOverweightSector Weight
Jun 21, 2023StifelreitHoldHold
May 22, 2023CL Kinginit—Buy
May 4, 2023Morgan Stanleymain—Underweight
Feb 22, 2023Morgan Stanleymain—Underweight

About Avanos Medical, Inc.

Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients. Its respiratory health segment includes closed airway suction systems and other airway management devices, marketed under prominent brands like Ballard, Microcuff, and Endoclear. For non-opioid pain relief, Avanos offers acute pain solutions, including On-Q and ambIT surgical pain pumps, along with Game Ready cold and compression therapy systems. It also features interventional pain solutions, providing minimally invasive therapies like Coolief for long-term pain alleviation. The company facilitates product access by selling directly to hospitals, various healthcare providers, and end-user facilities, in addition to utilizing third-party wholesale distributors. Originally incorporated in 2014 and known as Halyard Health, Inc., the company officially adopted the name Avanos Medical, Inc. in June 2018 and maintains its headquarters in Alpharetta, Georgia.

Sector
Healthcare
Industry
Medical - Devices
Country
US
Employees
2,287
Website
avanos.com

News

Your note

Sign in to keep a note on AVNS — it syncs with the Stock Master app.

Insider holders

AVNS insider holders
InsiderRelationLatest transactionDateShares held
BLACKFORD GARY DDirectorPurchaseAug 12, 20250
DELGADO SIGFRIDOOfficerStock Award(Grant)Mar 12, 202660,005
GALOVAN SCOTT MICHAELChief Financial OfficerStock Award(Grant)Mar 12, 2026139,824
GREINER MICHAEL CChief Executive OfficerStock Award(Grant)Mar 6, 2025224,264
HOLBROOK KERROfficerSaleNov 17, 202583,860
JAMES MOJIRADEGeneral CounselStock Award(Grant)Apr 21, 2025104,518

Institution ownership

AVNS institution ownership
Holder% heldSharesValueReported
Blackrock Inc.14.61%6,843,733171.02MMar 30, 2026
T. Rowe Price Investment Management, Inc.11.38%5,330,776133.22MMar 30, 2026
Brown Advisory Inc.4.76%2,231,19855.76MMar 30, 2026
Dimensional Fund Advisors LP4.38%2,052,35651.29MMar 30, 2026
Armistice Capital, LLC4.27%2,000,00049.98MMar 30, 2026
Vanguard Capital Management LLC4.21%1,971,96549.28MMar 30, 2026

Fund ownership

AVNS fund ownership
Holder% heldSharesValueReported
T. Rowe Price Small-Cap Value Fund, Inc.6.06%2,839,25470.95MMar 30, 2026
iShares Trust-iShares Core S&P Small-Cap ETF6.00%2,813,19570.30MMay 30, 2026
-Price (T.Rowe) U.S. Small-Cap Value Equity Trust3.94%1,848,13946.18MMar 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.01%1,410,62735.25MMar 30, 2026
iShares Trust-iShares Russell 2000 ETF2.56%1,198,69529.96MJun 29, 2026
Thrivent ETF Trust-Thrivent Small-Mid Cap Equity ETF2.03%951,47023.78MMar 30, 2026
Advertisement